Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4696126011 | Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
4696127019 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
4696128012 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampin 150 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethambutol hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Ethambutol hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pyrazinamide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Pyrazinamide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Rifampicin | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Rifampicin | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Isoniazid | true | Inferred relationship | Existential restriction modifier | 4 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Isoniazid | true | Inferred relationship | Existential restriction modifier | 4 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 4 | |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 4 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets